Guy Lacombe

Sherbrooke, QC, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Neuroprotective effects of SGLT2 inhibitors empagliflozin and dapagliflozin on Aβ1-42-induced neurotoxicity and neuroinflammation in cellular models of Alzheimer's disease.

Neuroprotective effects of SGLT2 inhibitors empagliflozin and dapagliflozin on Aβ1-42-induced neurotoxicity and neuroinflammation in cellular models of Alzheimer's disease.

Journal: Journal of Alzheimer's disease : JAD

Published: March 20, 2025

Risk Management During the Transition From Hospital to Home: A Multiple Case Study Documenting the Experience of Patients Living With a Major Neurocognitive Disorder, Their Caregivers, and Healthcare Professionals.

Risk Management During the Transition From Hospital to Home: A Multiple Case Study Documenting the Experience of Patients Living With a Major Neurocognitive Disorder, Their Caregivers, and Healthcare Professionals.

Journal: Journal of patient experience

Published: August 07, 2024

Viruses - a major cause of amyloid deposition in the brain.

Viruses - a major cause of amyloid deposition in the brain.

Journal: Expert review of neurotherapeutics

Published: August 08, 2023

Immunosenescence and Altered Vaccine Efficiency in Older Subjects: A Myth Difficult to Change.

Immunosenescence and Altered Vaccine Efficiency in Older Subjects: A Myth Difficult to Change.

Journal: Vaccines

Published: February 12, 2022

CCCDTD5: research diagnostic criteria for Alzheimer's Disease.

CCCDTD5: research diagnostic criteria for Alzheimer's Disease.

Journal: Alzheimer's & dementia (New York, N. Y.)

Published: April 17, 2020

Can an Infection Hypothesis Explain the Beta Amyloid Hypothesis of Alzheimer's Disease?

Can an Infection Hypothesis Explain the Beta Amyloid Hypothesis of Alzheimer's Disease?

Journal: Frontiers in aging neuroscience

Published: March 31, 2018

Orthostatic hypotension associated with executive dysfunction in mild cognitive impairment.

Orthostatic hypotension associated with executive dysfunction in mild cognitive impairment.

Journal: Journal of the neurological sciences

Published: April 27, 2017

A 3-Month Aerobic Training Program Improves Brain Energy Metabolism in Mild Alzheimer's Disease: Preliminary Results from a Neuroimaging Study.

A 3-Month Aerobic Training Program Improves Brain Energy Metabolism in Mild Alzheimer's Disease: Preliminary Results from a Neuroimaging Study.

Journal: Journal of Alzheimer's disease : JAD

Published: February 04, 2017

Multicenter Validation of an MMSE-MoCA Conversion Table.

Multicenter Validation of an MMSE-MoCA Conversion Table.

Journal: Journal of the American Geriatrics Society

Published: August 18, 2016

Impact of AP@LZ in the daily life of three persons with Alzheimer's disease: long-term use and further exploration of its effectiveness.

Impact of AP@LZ in the daily life of three persons with Alzheimer's disease: long-term use and further exploration of its effectiveness.

Journal: Neuropsychological rehabilitation

Published: April 30, 2016

Lower brain 18F-fluorodeoxyglucose uptake but normal 11C-acetoacetate metabolism in mild Alzheimer's disease dementia.

Lower brain 18F-fluorodeoxyglucose uptake but normal 11C-acetoacetate metabolism in mild Alzheimer's disease dementia.

Journal: Journal of Alzheimer's disease : JAD

Published: August 23, 2014

Elusive Alzheimer's disease: can immune signatures help our understanding of this challenging disease? Part 1: clinical and historical background.

Elusive Alzheimer's disease: can immune signatures help our understanding of this challenging disease? Part 1: clinical and historical background.

Journal: Discovery medicine

Published: February 05, 2013

Showing 1-12 of 13

Last Updated: 09/26/2026